Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SSEC Fentanyl for Acute Postoperative Pain in Pediatric Patients
NCT02395653Phase 3Completed
- Sponsor
- The Medicines Company
- Start
- Jun 2015
- Primary completion
- Sep 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of fentanyl in postoperative pain, sponsored by The Medicines Company. Primary endpoints: Assessment Of Participant's Ability To Use The SSEC up to 72 hours and Assessment Of Adherence Of The SSEC System To Skin up to 72 hours. Started Jun 2015; status: completed.
02
Drugs
fentanyl
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02395653.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02395653.